Home › NCT06095960
Telehealth Multi-Component Optional Model (MOM) Study
Comparative Evaluation of Telehealth Multi-Component Optional Model (MOM) of Postpartum Care Among Rural, Low-income, and Diverse Women
Who can join
Ages 18 to 44 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Pregnant women between 16-35 weeks gestation * Age 18-44 years * Ability to speak English, Spanish, or Marshallese * Participants may have either a vaginal birth or cesarean section birth Exclusion Criteria: * Type 1 diabetes on an insulin pump followed closely by endocrinology * Uncontrolled Type 2 diabetes * End stage renal disease followed closely by nephrology * ICU admission at any point during pregnancy or delivery hospitalization * Other maternal conditions requiring additional surgeries (i.e. cesarean hysterectomy or intrapartum or postpartum oophorectomy/appendectomy) * Incarceration * Mental disability limiting decision-making capacity * Uncontrolled chronic hypertension * HELLP syndrome during pregnancy * Sickle cell disease * Maternal heart condition or heart disease * Opioid use disorder * Lupus * Thrombophilia or blood clots * Need for blood transfusion during delivery hospitalization * Other maternal conditions or complications, known during pregnancy or delivery hospitalization, requiring prolonged hospitalization postpartum
About the study
The aim of this study is to conduct a comparative effectiveness evaluation using a randomized control trail design among diverse women to compare two postpartum care models: 1) Telehealth Multicomponent Optimal Model (Telehealth MOM) and 2) enhanced standard of care (ESoC). This study will address critical gaps in knowledge about how best to deliver comprehensive postpartum care that ensures timely identification and treatment of complications and meets the needs and preferences of diverse patients, including disproportionately-impacted racial groups and rural residents.
What is being tested
- Telehealth MOM (behavioral)
- Enhanced Standard of Care (other)
Sponsor: University of Arkansas · Participants: 1,500 · Started: Feb 12, 2024
Contact the study team
- Brett Rowland, MA · Phone: 4797138661
- Kacie Simpson, BS · Phone: 4797138661
Official record on ClinicalTrials.gov — NCT06095960
Locations in the U.S.
| Arkansas | UAMS El Dorado FMC, El Dorado (Not yet recruiting) UAMS Fayetteville FMC, Fayetteville UAMS Fort Smith FMC, Fort Smith UAMS Jonesboro FMC, Jonesboro (Not yet recruiting) UAMS Health Women's Center, Little Rock UAMS Springdale FMC, Springdale |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.